It was very hard for my multiple sclerosis (MS) patients to understand why they were singled out for MS, given the publicity given to theories of viral causation, popular at least since I started getting seriously interested in neurology as a 3rd year medical student in 1964. Herpes simplex (fever blisters) was a popular culprit, but we all know lots of people who’ve had them without coming down with MS.
The best explanation I could give them was of my med school classmate Marty, a Jewish kid from Pittsburgh. Graduating in 1966 at the height of American involvement in Vietnam, all my classmates entered the service within a few years. Marty was sent to Vietnam as a GMO (General Medical Officer). He was quickly sent back stateside as he developed a severe anemia. Why?
Well malaria was endemic in Vietnam, and anyone going over received an antiMalarial as prophylaxis. The malarial parasite does its damage by infecting red blood cells. The antiMalarial drug he received inhibited a red cell enzyme Glucose 6 Phosphate Dehydrogenase (G6PD), essentially starving the parasites. Marty had a partial deficiency of this enzyme. Such deficiencies are relatively common in areas endemic for Malaria, as it is protective, just as the sickle cell trait is protective against Malaria in Africa. A variety of other mutations in different red cell proteins arising in endemic areas are also protective (example Thalassemia in Greece, etc. etc.)
So if Marty had never been sent to Vietnam he would never have become anemic. I’d tell my patients that they had some biochemical difference (totally unknown back then) that made them susceptible to complications of infection with a common organism. Not very satisfying, but it was the best I could do.
In the case of another virus Epstein Barr Virus (EBV) which causes infectious mononucleosis, this explanation (50+ years later) turned out to be exactly correct. Not only that it shows the extreme subtlety of what ‘causation’ in medicine actually means.
Not only must the unlucky people getting MS after EBV infection be different biochemically, they must be infected with a particular variant of EBV (not all EBV is the same, just as not all people or SARS-CoV-2 are the same).
That’s the view from 30,000 feet. You can stop here but the full explanation is unsparingly technical. It is to be found in Cell vol. 186 pp. 5675 – 5676, 5708 – 5718 ’23 ]
Here goes.
Long term control of Epstein Barr Virus is mediated by cytotoxic T lymphocytes which recognize parts of EBV proteins. One such protein is EBNA1, and antibodies to amino acids #386 – #405 of EBNA1 cross react with amino acids #370 – #389 of a human protein called GlialCAM (for Glial Cell Adhesion Molecule) which is important in maintaining the myelin sheath around axons in the brain (MS is basically a destructive immune attack on myelin).
Such an antibody is called autoreactive, in the sense that it is reacting to a normal human protein. Cells producing autoreactive antibodies (autoreactive cells) are normally eliminated by cytotoxic natural killer cells. In the case of EBV specific T cells they are eliminated by natural killer cells expressing proteins NKG2C and NKG2D. They target the autoreactive GlialCAM specific autoreactive B cells. Some people have deletion of the gene coding for NKG2C rendering them more susceptible to MS after EBV infection.
But wait, there’s more. There are many EBV variants and some of them upregulate another human protein HLA-E by containing another protein (LMP1) which stabilizes HLA-E. HLA-E blunts the natural killer cell attack on autoreactive GlialCAM cells.
So it’s a delicate dance of unfortunate events ‘causing’ MS. A mild genetic defect in the human, and a genetic variant in the virus, both of which must occur for causation.
Who knew that medical causation could be so subtle.